The translational value of non-human primates in preclinical research on infection and immunopathology

Eur J Pharmacol. 2015 Jul 15:759:69-83. doi: 10.1016/j.ejphar.2015.03.023. Epub 2015 Mar 23.

Abstract

The immune system plays a central role in the defense against environmental threats - such as infection with viruses, parasites or bacteria - but can also be a cause of disease, such as in the case of allergic or autoimmune disorders. In the past decades the impressive development of biotechnology has provided scientists with biological tools for the development of highly selective treatments for the different types of disorders. However, despite some clear successes the translation of scientific discoveries into effective treatments has remained challenging. The often-disappointing predictive validity of the preclinical animal models that are used in the selection of the most promising vaccine or drug candidates is the Achilles heel in the therapy development process. This publication summarizes the relevance and usage of non-human primates as pre-clinical model in infectious and autoimmune diseases, in particular for biologicals, which due to their high species-specificity are inactive in lower species.

Keywords: Animal model; Autoimmunity; Bacterial infection; Parasitic infection; Transplantation; Viral infection.

Publication types

  • Review

MeSH terms

  • Animals
  • Autoimmune Diseases / drug therapy*
  • Autoimmune Diseases / immunology
  • Communicable Diseases / drug therapy*
  • Communicable Diseases / immunology
  • Disease Models, Animal*
  • Drug Evaluation, Preclinical / methods*
  • Humans
  • Primates
  • Species Specificity
  • Translational Research, Biomedical / methods*